Isodiol International Inc. Stock

ISOLF

CA46500L2003

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 10:49:49 2026-06-26 EDT			5-day change	1st Jan Change
0.000001 ^USD	-.--%		-.--%	-

19-10-09	Isodiol International Inc. Enters into Strategic Relationship with Vitamin Shoppe Inc	CI
18-12-20	Isodiol International Inc. Appoints Michael Cancelleri as Chief Executive Officer and Chairman of the Board of Directors	CI

Valuation: Isodiol International Inc.

Market Cap	3.91M 2.76M 2.42M 2.23M 2.06M 264M 3.99M 26.85M 10.43M 129M 10.36M 10.13M 449M	P/E 2018	-4.94x	P/E 2019	-0.37x
Enterprise Value	9.13M 6.44M 5.65M 5.21M 4.82M 617M 9.32M 62.69M 24.36M 302M 24.18M 23.65M 1.05B	EV / Sales 2018	12.6x	EV / Sales 2019	2.48x
Free-Float	100%	Yield 2018 *	-	Yield 2019	-

* Estimated data More valuation ratios

Chart: Isodiol International Inc.

Dynamic Chart

Latest news : Isodiol International Inc.

19-10-09	Isodiol International Inc. Enters into Strategic Relationship with Vitamin Shoppe Inc	CI
18-12-20	Isodiol International Inc. Appoints Michael Cancelleri as Chief Executive Officer and Chairman of the Board of Directors	CI
18-05-30	Liberty Health Sciences Inc. Signs Licensing Agreement with Isodiol International Inc. to Provide A Complementary Suite of Medical Cannabis Products to Patients in Florida and Massachusetts	CI
18-05-24	Sundial Announces Letter of Intent for the Supply of 99.5%+ CBD Isolate from Isodiol International	CI
18-05-07	Scythian Biosciences Corp. Signs an Agreement with Isodiol International Inc. to Import and Distribute Isodiol Products	CI
18-05-06	Isodiol International Inc. announced that it has received CAD 2 million in funding from Scythian Biosciences Corp.	CI
17-12-26	Isodiol International Inc. announced that it has received CAD 30.1 million in funding from Serruya Private Equity, Scythian Biosciences Corp., Liberty Health Sciences Inc.	CI
17-11-01	Nutritional High International Inc. and Isodiol International Inc. Announce Distribution Relationship	CI
17-07-20	Isodiol International Inc. Signs Definitive Licensing Agreement with Canopy Growth Corporation for Canadian and International Distribution	CI

More news

Managers and Directors: Isodiol International Inc.

Manager	Title	Age	Since
Marcos Agramont CEO	Chief Executive Officer	-	2017-05-23
Andrew Alvis DFI	Director of Finance/CFO	-	-
Marvin Washington PRN	Corporate Officer/Principal	-	2018-08-29

Director	Title	Age	Since
Marcos Agramont BRD	Director/Board Member	-	2017-05-23
Marvin Washington BRD	Director/Board Member	-	2018-08-29
Leonardo Matesanz BRD	Director/Board Member	-	2018-11-20

More insiders

Isodiol International Inc. is a Canada-based company, which is engaged in product development, sales, marketing, and distribution of hemp-based consumer packaged goods (CPG) and solutions. The Company supplies industrial hemp derivatives for medicinal formulations in the nutraceutical, cosmetic, and pharmaceutical markets. It grows and harvests hemp on an industrial scale, then processes and extracts cannabidiol (CBD) for distribution. It has commercialized naturally isolated CBD, including micro-encapsulations, and nanotechnology for consumables and topical skin care products. The Company's ready to label program offers a range of CBD products ready to be added or developed for various brands. The Company is focused on developing over-the-counter and pharmaceutical drugs and international expansion into Latin America, Asia, and Europe.

Employees

Sector

Pharmaceuticals

More about the company

Stock Market
Stocks
ISOLF Stock

Google lets you customize your preferred sources.

Choose MarketScreener

Current year	0		0
1 year	0		0
3 years	0		0
5 years	0		0.29
10 years	0		16.9

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ISODIOL INTERNATIONAL INC.	-.--%	-.--%	-	-	128
YUNNAN BAIYAO GROUP CO.,LTD	+0.04%	+1.46%	-13.03%	-6.44%	12.76B
BEIJING TONGRENTANG CO., LTD	+1.34%	+0.65%	-34.33%	-56.33%	4.72B
DONG-E-E-JIAO CO., LTD.	+0.15%	+2.06%	-8.54%	-4.43%	4.41B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+1.14%	+4.30%	+22.79%	-2.44%	3.89B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	+0.52%	+0.20%	+4.48%	-38.18%	3.78B
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.	+3.03%	+5.92%	-8.04%	-13.49%	3.22B
TASLY PHARMACEUTICAL GROUP CO., LTD	+0.21%	+3.38%	-11.41%	+2.48%	3.09B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	+3.96%	+4.58%	-4.78%	-21.76%	2.44B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+2.10%	+9.66%	-5.56%	+44.84%	1.81B
Average	+1.25%	+2.01%	-6.49%	-10.64%	4.01B
Weighted average by Cap.	+0.94%	+1.31%	-8.55%	-13.18%

	2018	2019
Net sales	19.14M 13.49M 11.83M 10.93M 10.1M 1.29B 19.52M 131M 51.04M 632M 50.67M 49.56M 2.19B	22.25M 15.69M 13.76M 12.7M 11.74M 1.5B 22.69M 153M 59.33M 735M 58.91M 57.62M 2.55B
Net income	-36.02M -25.4M -22.28M -20.57M -19M -2.43B -36.74M -247M -96.06M -1.19B -95.37M -93.28M -4.13B	-126M -88.78M -77.87M -71.89M -66.43M -8.5B -128M -864M -336M -4.16B -333M -326M -14.44B
Net Debt	-15.55M -10.96M -9.62M -8.88M -8.2M -1.05B -15.86M -107M -41.47M -514M -41.17M -40.27M -1.78B	5.22M 3.68M 3.23M 2.98M 2.76M 353M 5.33M 35.84M 13.93M 173M 13.83M 13.52M 599M

Isodiol International Inc. Stock

Stocks

ISOLF

CA46500L2003

Pharmaceuticals

Valuation: Isodiol International Inc.

Chart: Isodiol International Inc.

Latest news : Isodiol International Inc.

Course Extremes

Managers and Directors: Isodiol International Inc.

Alternative Medicine

Financials

Company Profile